Literature DB >> 31115977

Management der Dupilumab-assoziierten Konjunktivitis beim atopischen Ekzem.

Nora Aszodi1, Stephan Thurau2, Marlene Seegräber1,3, Marjolein de Bruin-Weller4, Andreas Wollenberg1,3.   

Abstract

Year:  2019        PMID： 31115977     DOI： 10.1111/ddg.13809_g

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN： 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  4 in total

Review 1.  [Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?]

Authors:  Stephan Traidl; Annice Heratizadeh
Journal:  Dermatologie (Heidelb)       Date:  2022-06-01

Review 2.  A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis.

Authors:  Gaurav Agnihotri; Katherine Shi; Peter A Lio
Journal:  Drugs R D       Date:  2019-12

3.  Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.

Authors:  Ashish Bansal; Eric L Simpson; Amy S Paller; Elaine C Siegfried; Andrew Blauvelt; Marjolein de Bruin-Weller; Jonathan Corren; Lawrence Sher; Emma Guttman-Yassky; Zhen Chen; Nadia Daizadeh; Mohamed A Kamal; Brad Shumel; Paola Mina-Osorio; Leda Mannent; Naimish Patel; Neil M H Graham; Faisal A Khokhar; Marius Ardeleanu
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

4.  Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae.

Authors:  Magdalena Z Popiela; Ramez Barbara; Andrew M J Turnbull; Emma Corden; Beatriz Suarez Martinez-Falero; Daniel O'Driscoll; Michael R Ardern-Jones; Parwez N Hossain
Journal:  Eye (Lond)       Date:  2021-01-28       Impact factor: 3.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.